News



18/Sep/2020

CreaGen positions itself for further growth by expanding its current products' business to better meet the growing demands of the industry to obtain difficult to find and make organic and organometallic compounds. WOBURN, MA -- CreaGen Biosciences is a specialty drug discovery chemistry service company ("CreaGen"), today announced its next step in meeting the growing demands of the drug discovery industry by acquiring Prime Organics' Catalogue Business. Prime Organics closed its doors after almost 20 years of business this May. Acquiring Prime's Catalogue Business, demonstrates CreaGen's continued evolution to respond to the demands of the industry in turn response to the industry's need to find it extremely challenging to obtain difficult to find and complex organic and organometallic compounds to make. CreaGen will continue to provide their clients their full range of drug discovery chemi




Subscribe


Sign up for CreaGen Inc newsletter to receive all the news.




Social networks



Twitter

#WeCare




Contact us




Send us an email

rrajur@creageninc.com



Subscribe


Sign up for Medicare newsletter to receive all the news offers and discounts from Medicare eye clinic.




Social networks



Twitter

#WeCare





© CreaGen Inc 2019. All rights reserved. Designed by Inqude



© CreaGen Inc 2019. All rights reserved. Designed by Inqude